Next Article in Journal
Discovery of Single Nucleotide Polymorphisms in Complex Genomes Using SGSautoSNP
Next Article in Special Issue
Inhibitors of HIV-1 Reverse Transcriptase—Associated Ribonuclease H Activity
Previous Article in Journal / Special Issue
Computer-Aided Approaches for Targeting HIVgp41
Biology 2012, 1(2), 339-369; doi:10.3390/biology1020339

Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections

1 National Center for Biodefense and Infectious Disease, School of Systems Biology, George Mason University, 10900 University Blvd, Manassas, VA 20108, USA 2 Molecular Virology Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, 9000 Rockville Pike, Bethesda, MD 20810, USA
* Author to whom correspondence should be addressed.
Received: 29 June 2012 / Revised: 3 August 2012 / Accepted: 13 August 2012 / Published: 24 August 2012
(This article belongs to the Special Issue Structural and Molecular Biology of HIV)
View Full-Text   |   Download PDF [451 KB, 27 August 2012; original version 24 August 2012]   |   Browse Figures


Gene silencing via non-coding RNA, such as siRNA and miRNA, can occur at the transcriptional, post-transcriptional, and translational stages of expression. Transcriptional gene silencing (TGS) involving the RNAi machinery generally occurs through DNA methylation, as well as histone post-translational modifications, and corresponding remodeling of chromatin around the target gene into a heterochromatic state. The mechanism by which mammalian TGS occurs includes the recruitment of RNA-induced initiation of transcriptional gene silencing (RITS) complexes, DNA methyltransferases (DNMTs), and other chromatin remodelers. Additionally, virally infected cells encoding miRNAs have also been shown to manipulate the host cell RNAi machinery to induce TGS at the viral genome, thereby establishing latency. Furthermore, the introduction of exogenous siRNA and shRNA into infected cells that target integrated viral promoters can greatly suppress viral transcription via TGS. Here we examine the latest findings regarding mammalian TGS, specifically focusing on HIV-1 infected cells, and discuss future avenues of exploration in this field.
Keywords: HIV; miRNA; RNAi; transcriptional gene silencing; chromatin remodeler HIV; miRNA; RNAi; transcriptional gene silencing; chromatin remodeler
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Sampey, G.C.; Guendel, I.; Das, R.; Jaworski, E.; Klase, Z.; Narayanan, A.; Kehn-Hall, K.; Kashanchi, F. Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections. Biology 2012, 1, 339-369.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Biology EISSN 2079-7737 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert